Dendreon Corporation Stock Nasdaq
Equities
US24823Q1076
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
2015 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- Stock
- Stock